Correlation Between Checkpoint Therapeutics and Calithera Biosciences

Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Calithera Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Calithera Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Checkpoint Therapeutics and Calithera Biosciences, you can compare the effects of market volatilities on Checkpoint Therapeutics and Calithera Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Calithera Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Calithera Biosciences.

Diversification Opportunities for Checkpoint Therapeutics and Calithera Biosciences

0.0

Correlation Coefficient

Checkpoint Therapeutics  Calithera Biosciences

Pay attention - limited upside

The 3 months correlation between Checkpoint and Calithera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Calithera Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calithera Biosciences and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Calithera Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calithera Biosciences has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Calithera Biosciences go up and down completely randomly.

Pair Corralation between Checkpoint Therapeutics and Calithera Biosciences

If you would invest  289.00  in Checkpoint Therapeutics on November 29, 2024 and sell it today you would lose (6.50) from holding Checkpoint Therapeutics or give up 2.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Checkpoint Therapeutics  vs.  Calithera Biosciences

Checkpoint Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Checkpoint Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Calithera Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Calithera Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Calithera Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Checkpoint Therapeutics and Calithera Biosciences

The main advantage of trading using opposite Checkpoint Therapeutics and Calithera Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Calithera Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calithera Biosciences will offset losses from the drop in Calithera Biosciences' long position.

The idea behind Checkpoint Therapeutics and Calithera Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.